Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000479594 | SCV000573210 | uncertain significance | not provided | 2024-07-23 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001085744 | SCV000756167 | likely benign | Alstrom syndrome | 2025-01-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002383930 | SCV002691260 | likely benign | Cardiovascular phenotype | 2023-10-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001085744 | SCV001459594 | uncertain significance | Alstrom syndrome | 2020-01-24 | no assertion criteria provided | clinical testing |